Creative Planning Raises Stake in The Allstate Co. (NYSE:ALL)

Creative Planning grew its holdings in shares of The Allstate Co. (NYSE:ALL) by 5.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 66,823 shares of the insurance provider’s stock after acquiring an additional 3,280 shares during the quarter. Creative Planning’s holdings in Allstate were worth $12,673,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in ALL. Northwest Investment Counselors LLC bought a new stake in Allstate in the first quarter worth $26,000. Versant Capital Management Inc boosted its holdings in Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 78 shares during the period. Family Firm Inc. bought a new position in Allstate during the 2nd quarter worth approximately $38,000. MCF Advisors LLC increased its stake in Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares during the period. Finally, First Command Advisory Services Inc. bought a new stake in Allstate in the second quarter valued at approximately $58,000. 76.47% of the stock is currently owned by institutional investors.

Insider Activity

In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the sale, the chief executive officer now directly owns 88,552 shares in the company, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Thomas J. Wilson sold 90,000 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at $15,880,915.68. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 192,530 shares of company stock worth $34,967,665 over the last 90 days. 1.80% of the stock is currently owned by insiders.

Allstate Trading Down 1.4 %

Shares of NYSE ALL opened at $192.64 on Tuesday. The stock has a market cap of $50.84 billion, a P/E ratio of 42.53, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36. The Allstate Co. has a 1 year low of $121.70 and a 1 year high of $198.79. The firm has a 50-day moving average of $187.08 and a 200 day moving average of $173.96.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The firm had revenue of $15.71 billion for the quarter, compared to analysts’ expectations of $14.04 billion. During the same period in the previous year, the firm posted ($4.42) EPS. The business’s revenue for the quarter was up 12.4% compared to the same quarter last year. As a group, sell-side analysts expect that The Allstate Co. will post 15.19 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently commented on ALL shares. Jefferies Financial Group lifted their target price on shares of Allstate from $217.00 to $231.00 and gave the stock a “buy” rating in a research note on Wednesday, October 9th. Keefe, Bruyette & Woods upped their price objective on shares of Allstate from $199.00 to $208.00 and gave the company an “outperform” rating in a research note on Monday, August 12th. StockNews.com cut Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. Morgan Stanley increased their price objective on Allstate from $202.00 to $215.00 and gave the stock an “overweight” rating in a report on Monday. Finally, JPMorgan Chase & Co. boosted their target price on Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $206.44.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.